NEW YORK (

TheStreet

) --

Hi-Tech Pharmacal

(Nasdaq:

HITK

) hit a new 52-week high Tuesday as it is currently trading at $29.36, above its previous 52-week high of $29.17 with 15,069 shares traded as of 9:56 a.m. ET. Average volume has been 155,400 shares over the past 30 days.

Hi-Tech Pharmacal has a market cap of $367.8 million and is part of the

health care

sector and

drugs

industry. Shares are up 16.4% year to date as of the close of trading on Friday.

TheStreet Recommends

Hi-Tech Pharmacal Co., Inc. develops, manufactures, markets, and sells generic, prescription, over-the-counter (OTC), and nutritional products in liquid and semisolid dosage forms in the United States. The company has a P/E ratio of 10.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

  • Practice your HITK trading strategies and win cash in our stock game.

TheStreet Ratings rates Hi-Tech Pharmacal as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full

Hi-Tech Pharmacal Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

null